Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference39 articles.
1. Renal cell carcinoma pathology in 2021: 'new need for renal cancer immune profiling';Sobottka;Curr. Opin. Urol.,2021
2. Glutathione metabolism in renal cell carcinoma progression and implications for therapies;Xiao;Int J. Mol. Sci.,2019
3. Renal cell carcinoma in one year: Going inside the news of 2017 - a report of the main advances in RCC cancer research;Mosillo;Cancer Treat. Rev.,2018
4. Combination of CTLA-4 and PD-1 blockers for treatment of cancer;Rotte;J. Exp. Clin. Cancer Res.: CR,2019
5. Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: Current paradigms, use of immunotherapy, and future directions;Lalani;Eur. Urol.,2019
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies;Journal of Translational Medicine;2024-09-11
2. Oncolytic viruses facilitate tumor immunotherapy;SCIENTIA SINICA Vitae;2024-09-01
3. Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination;Cancer Letters;2024-08
4. Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells;Anti-Cancer Agents in Medicinal Chemistry;2024-07-24
5. Current Strategies to Improve Chimeric Antigen Receptor T (CAR-T) Cell Persistence;Cureus;2024-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3